Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05318573
Title A Study to Evaluate Safety, Efficacy of FF-10832 in Combination With Pembrolizumab in Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fujifilm Pharmaceuticals U.S.A., Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine, Center for Adv Medicine RECRUITING Saint Louis Missouri 63110 United States Details
Comprehensive Cancer Centers of Nevada - Southern Hills RECRUITING Las Vegas Nevada 89148 United States Details
Atlantic Health System / Morristown Medical Center COMPLETED Morristown New Jersey 07960 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
TriHealth Cancer Institute; Good Samaritan Hospital RECRUITING Cincinnati Ohio 45220 United States Details
Providence Cancer Institute Franz Clinic RECRUITING Portland Oregon 97213 United States Details
Hospital of the Univ of Pennsylvania Perlman Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute COMPLETED Nashville Tennessee 37203 United States Details
University of Texas Southwestern Medical Center RECRUITING Dallas Texas 75235 United States Details
Virginia Cancer Specialists, PC RECRUITING Fairfax Virginia 22031 United States Details
University of Wisconsin Clinical Science Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field